首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Diabetes & Metabolism

Diabetes & Metabolism杂志,由Elsevier Masson出版,于1996年创刊,Bimonthly,出版语言Multi-Language,ISSN:1262-3636,E-ISSN:1878-1780。

投稿咨询
Diabetes & Metabolism
Diabetes & Metabolism
Diabetes & Metabolism
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
2区
影响因子
5.8
CiteScore
8.1
期刊收录
SCI、SCIE

Diabetes & Metabolism(中文译名:《糖尿病与新陈代谢》),ISSN:1262-3636,EISSN:1878-1780,是Elsevier Masson出版的国际性学术期刊,创刊于1996年,以Bimonthly形式稳定发行,2026年总发文量约73篇。该刊采用非OA开放访问,学科归属为医学 - 内分泌学与代谢。该刊是医学、内分泌学与代谢领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达5.8,2025年期刊CiteScore为8.1,2025年期刊自引率约1.7%,在中科院期刊分区体系中位列医学大类2区,在所属学科领域具备高学术影响力与国际认可度。Diabetes & Metabolism长期聚焦医学、内分泌学与代谢及相关产业的技术应用前沿,平均审稿周期较慢,6-12周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、内分泌学与代谢领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,FranceItaly、USA、CHINA MAINLAND、England、Belgium、Canada等为核心发文国家与地区;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)ASSISTANCE PUBLIQUE HOPITAUX PARIS (APHP)、UNIVERSITE DE PARIS、SORBONNE UNIVERSITE、INRAE、CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)、UNIVERSITY OF LIEGE等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
ENDOCRINOLOGY & METABOLISM 内分泌学与代谢
2区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
ENDOCRINOLOGY & METABOLISM 内分泌学与代谢
2区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
ENDOCRINOLOGY & METABOLISM 内分泌学与代谢
2区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ENDOCRINOLOGY & METABOLISM SCIE Q1 34 / 198

83.1

学科:ENDOCRINOLOGY & METABOLISM SCIE Q1 38 / 198

81.06

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ENDOCRINOLOGY & METABOLISM SCIE Q1 39 / 193

80.1

学科:ENDOCRINOLOGY & METABOLISM SCIE Q1 32 / 193

83.68


中国学者近期发文

1
Advanced automated insulin delivery in inpatients receiving nutritional support: a single-center, open-label, randomised controlled tria

Author:Cai, Yunying; Ma, Le; Xun, Linting; Chen, Yanmin; Su, Heng

Journal: DIABETES & METABOLISM. 2026; Vol. 52, Issue 3, pp. -. DOI: 10.1016/j.diabet.2026.101758

2
BMD: Toward mechanistically-informed and fracture-specific treatment thresholds in diabetic bone diseas

Author:Yang, Yuan

Journal: DIABETES & METABOLISM. 2026; Vol. 52, Issue 3, pp. -. DOI: 10.1016/j.diabet.2026.101759

3
HLA-guided identification of monogenic diabetes in antibody-negative type 1 diabetes: frequency and characteristic

Author:Chen, Yan; Yin, Min; Xie, Yuting; Deng, Chao; Xie, Zhiguo; Huang, Gan; Luo, Shuoming; Zhou, Zhiguang; Li, Xia

Journal: DIABETES & METABOLISM. 2026; Vol. 52, Issue 2, pp. -. DOI: 10.1016/j.diabet.2026.101741

4
A clinical prediction model for beta cell monogenetic diabetes in Chinese patients with early-onset type 2 diabete

Author:Sun, Siyu; Gong, Siqian; Ba, Tianhao; Li, Meng; Liu, Wei; Zhang, Rui; Ma, Yumin; Wang, Fang; Cai, Xiaoling; Luo, Yingying; Zhang, Simin; Zhou, Lingli; Zhu, Yu; Zhang, Xiuying; Chen, Jing; Chen, Ling; Wu, Jing; Gao, Leili; Zhou, Xianghai; Zhong, Liyong; Wang, Xirui; Xiao, Xinhua; Gu, Weijun; Yang, Jinkui; Wang, Qiuping; Deng, Wei; Qi, Lin; Wang, Wenbo; Lian, Hong; Li, Yufeng; Ren, Qian; Han, Xueyao; Ji, Linong

Journal: DIABETES & METABOLISM. 2026; Vol. 52, Issue 2, pp. -. DOI: 10.1016/j.diabet.2026.101729

5
The association between hip fractures and type 2 diabetes in the elderl

Author:Yuan, Shu; Li, Zi-Li; Hu, Jing

Journal: DIABETES & METABOLISM. 2025; Vol. 51, Issue 5, pp. -. DOI: 10.1016/j.diabet.2025.101673

6
SGLT2 inhibitor, GLP-1 receptor agonist, and dementia ris

Author:Lai, Shih-Wei

Journal: DIABETES & METABOLISM. 2025; Vol. 51, Issue 4, pp. -. DOI: 10.1016/j.diabet.2025.101663

7
Global Burden of type 2 diabetes in non-elderly individuals 1990 to 2021 and projections for 2050: a systematic analysis of the 2021 Global Burden of Diseas

Author:He, Qian; Wu, Wenjing; Chen, Junnian; Zhou, Haofeng; Ding, Gangyu; Lai, Shuiqing; Kuo, Andy Y. T.; Wan, Heng; Lin, Beisi; Wu, Hongjiang; Kong, Alice P. S.; Guan, Haixia; Cao, Huanyi

Journal: DIABETES & METABOLISM. 2025; Vol. 51, Issue 4, pp. -. DOI: 10.1016/j.diabet.2025.101660

8
Glucagon-like peptide-1 receptor agonists and acute pancreatiti

Author:Liao, Kuan-Fu; Lai, Shih-Wei

Journal: DIABETES & METABOLISM. 2025; Vol. 51, Issue 4, pp. -. DOI: 10.1016/j.diabet.2025.101666

9
Increased fatty acid-binding protein 4 levels are associated with the risk of developing retinopathy in type 2 diabetes mellitus patient

Author:Liu, Yan; Ma, Kaihui; Zhang, Aiying; Cui, Yun; Zhao, Hui; Li, Xinhua; Zhao, Ke

Journal: DIABETES & METABOLISM. 2025; Vol. 51, Issue 4, pp. -. DOI: 10.1016/j.diabet.2025.101653

10
Comparative study of SGLT2 inhibitors and metformin: Evaluating first-line therapies for dementia prevention in type 2 diabete

Author:Sun, Mingyang; Wang, Xiaoling; Lu, Zhongyuan; Yang, Yitian; Lv, Shuang; Miao, Mengrong; Chen, Wan-Ming; Wu, Szu-Yuan; Zhang, Jiaqiang

Journal: DIABETES & METABOLISM. 2025; Vol. 51, Issue 4, pp. -. DOI: 10.1016/j.diabet.2025.101655


在线咨询

Diabetes & Metabolism

国际简称:DIABETES METAB参考译名:糖尿病与新陈代谢

年发文量:73 CiteScore:8.1 是否预警:否 Gold OA文章占比:25.73% 研究类文章占比:89.04%

杂志社联系方式:MASSON EDITEUR, 21 STREET CAMILLE DESMOULINS, ISSY, MOULINEAUX CEDEX 9, FRANCE, 92789

Diabetes & Metabolism